Loading stock data…
SRTS
$3.98+0.01 (+0.25%)
Market ClosedLast close May 1
Sensus Healthcare, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sensus Healthcare, Inc. in the Healthcare sector is trading at $3.98. The stock is currently 33% below its 52-week high of $5.92, remaining 0.7% below its 200-day moving average. Technical signals show oversold RSI of 28 and bearish MACD signal, explaining why SRTS maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 28) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.98
Potential Upside
5%
Whystock Fair Value$4.18
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of tr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$65.41M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.28
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-16.05%
Volume
Today's trading volume
18,045
Recent News
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now
Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations
Sensus Healthcare’s analyst narrative has shifted, with one price target now set at US$7.50 and another adjusted to US$6 from US$8. Supportive research ties the US$7.50 view to confidence in the SRT-100/Vision platform and potential reimbursement changes in 2026. In contrast, more cautious voices cite recent quarterly weakness and customer concentration as reasons for the lower US$6 stance. As you read on, you will see how these differing targets shape the evolving story around expectations...
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
As you might know, Sensus Healthcare, Inc. ( NASDAQ:SRTS ) last week released its latest full-year, and things did not...
Sensus Healthcare, Inc. Q4 2025 Earnings Call Summary
Moby summary of Sensus Healthcare, Inc.'s Q4 2025 earnings call
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
Sensus Healthcare Inc (SRTS) outlines its path to profitability in 2026 amid revenue declines and increased international demand.